World Stroke Day 2020: Generating knowledge by capturing Real-World Data
As we do every year, this Thursday, October 29th, we are celebrating World Stroke Day, with the goal of providing more visibility for this disease. In Spain, more than 187 persons out of every 100,000 are affected every year, according to data from the Spanish Society of Neurology (SEN).
Successful implementation of the Spanish Registry of COVID-19 Screening of Asymptomatic Pregnant Women, developed with Persei vivarium technology
In March of 2020, the Spanish Registry of COVID-19 Screening of Asymptomatic Pregnant Women was implemented by its principal investigator, Dr. Óscar Martínez (Puerta de Hierro University Hospital). The registry is managed with technology from our company, Persei vivarium.
Real-World Data in Oncology: Towards a better understanding of the disease
It is undeniable that clinical studies are a fundamental resource for the improvement of the understanding of and approach to diseases, through the information that comes out of research into the disease, new treatments, therapies, etc. In this environment, the need to use Real-World Data to complement the traditional clinical studies is becoming more and more obvious.
“New Normality” Digital Health Experience
On the 1st of June I began my internship at Persei vivarium. At that time, the Spanish Government was implementing de-escalation measures to ease the complete lockdown caused by Covid-19. The digital health sector, to which Persei vivarium belongs, has been growing and its applications in the fight against the Covid-19 pandemic is just one of the many reasons.
Challenges and benefits of patient education using technology platforms
Increasingly, in recent times, we are observing that patients want to be more informed and involved in their disease, demanding information and education on a voluntary and individual basis using different sources and platforms. In this context, patient education using technology platforms has become a reality.
Technology, the key to generating clinical studies during COVID-19
As the COVID-19 pandemic spread around the world, the negative impact of the virus has become more obvious, even in the development of clinical studies of other diseases. With the travel restrictions imposed by governments, and the fear of contracting the virus among both the patients participating in the studies as well as the monitors, people stopped coming to hospitals.